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Abstract
Background: The paracrine effect is likely the major mechanism of the adipose-derived stem cell (ASC)-mediated
cardioprotective effect. However, the exact composition and nature of ASC-released paracrine factors remain elusive.
In the present study, we examined the effect of osteoprotegerin (OPG), a stem cell-released decoy receptor for death
ligand, on the survival of cardiomyocytes exposed to oxidative stress.
Methods: The production of OPG from ASCs under oxidative stress was determined by ELISA and immunohistochemistry.
The effects of OPG and the OPG-containing conditioned media of ASCs on the survival of cardiomyocytes were
determined using a cell viability assay.
Results: Hydrogen peroxide (H2O2) significantly increased OPG production from ASCs in vitro, and OPG production
from the ASCs transplanted into the ischemia–reperfusion-injured heart was also observed. OPG significantly
attenuated cardiomyocyte death in vitro. OPG-containing conditioned media of ASCs also significantly protected
cardiomyocytes. Delivery of siRNA specific to OPG significantly decreased the OPG production of ASCs, and also
offset the protective effect of the conditioned media of ASCs.
Conclusions: Our study strongly suggests that OPG is one of the prosurvival factors released from ASCs that may
contribute to the ASC-mediated cardioprotection and calls for further studies to elucidate detailed underlying
mechanisms.
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Background
Previous studies have reported the cardioprotective ef-
fect of adipose-derived stem cells (ASCs) [1, 2]. Evidence
suggests that the regenerative effect of transplanted stem
cells is mainly mediated by paracrine factors [3, 4], and
stem cell-released factors varied depending on the
source of stem cells and the stimuli they were exposed
to [5, 6]. Therefore, it is important to identify soluble
factors contributing to the beneficial effect (i.e., host cell
protection) of stem cells under a specified condition
because a clinically effective stem cell-based therapeutic
strategy can be developed based on such information.
Osteoprotegerin (OPG) is known to be produced by
stem cells, fibroblasts, and endothelial cells [7]. OPG is
a soluble decoy receptor that binds to tumor necrosis
factor-related apoptosis-inducing ligand (TRAIL), thereby
neutralizing TRAIL-mediated apoptotic signaling [8].
TRAIL initiates signaling cascade by binding to corre-
sponding receptors such as TRAIL-R1, TRAIL-R2,
TRAIL-R3, and TRAIL-R4 [9]. TRAIL-R1 and TRAIL-
R2 can promote cell death signaling cascades, while
TRAIL-R3 and TRAIL-R4 antagonize the TRAIL-R1
and TRAIL-R2-mediated apoptotic signaling by com-
petitively binding to TRAIL [10]. In the present study,
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we examined the effect of OPG on the survival of cardi-
omyocytes exposed to oxidative stress.
Methods
Culture of ASCs and H9c2 cells
Four vials of ASCs from four different human donors
(StemPro human adipose-derived stem cells) were pur-
chased from Invitrogen (Carlsbad, CA, USA), and rat
cardiomyoblast cell line H9c2 cells were purchased
from ATCC (Manassas, VA, USA). ASCs and H9c2 cells
were maintained according to the manufacturer’s in-
structions. We used low-glucose Dulbecco’s modified
Eagle’s medium (DMEM; Gibco, Waltham, MA, USA)
and high-glucose DMEM (Gibco) containing 10% fetal
bovine serum (FBS; Gibco) and 1% penicillin–strepto-
mycin (Gibco) for ASCs and H9c2 cells, respectively.
Isolation rat neonatal ventricular cardiomyocytes
All experimental procedures for animal studies were
approved by the committee for the care and use of la-
boratory animals of Catholic Kwandong University, and
were performed in accordance with the committee’s
guidelines and regulations (CKU01-2015-003-1). Neo-
natal rat ventricular cardiomyocytes were isolated and
purified by enzymatic methods following a protocol
published previously [11].
Ischemia–reperfusion injury and transplantation of ASCs
Male 8-week-old Sprague–Dawley rats (250 g) were
used. The animals were put under anesthesia with zoletil
(30 mg/kg) and xylazine (10 mg/kg). The left anterior
descending coronary artery was occluded using a 6-0 silk
suture (Johnson & Johnson, New Brunswick, NJ, USA).
After 60 min of occlusion, the left anterior descending
coronary artery was released for reperfusion, followed
by cell transplantation. For transplantation, 1 × 106 cells
were suspended in 30 μl PBS and injected to border
zone using a 0.3-ml insulin syringe (BD Pharmingen,
Franklin Lakes, NJ, USA).
Statistical analyses
Quantitative data were expressed as the means ± SD of
at least three independent experiments. For statistical
analysis, one-way ANOVA with Bonferroni correction
was performed using OriginPro 8 SR4 software (version
8.0951; OriginLab Corporation, Northampton, MA,
USA) if there were more than three groups. p < 0.05
was considered statistically significant.
Additional methods are available in Additional file 1.
Results
Hydrogen peroxide induced apoptosis of cardiomyocytes
Hydrogen peroxide (H2O2), a member of endogenous re-
active oxygen species (ROS), has been used to simulate
oxidative stress [12, 13]. When H9c2 and primary cultured
rat cardiomyocytes were treated with increasing concen-
tration of H2O2 for 48 hours, the viability of both H9c2
(Additional file 2: Figure S1A) and primary (Additional
file 2: Figure S1B) cardiomyocytes significantly decreased
with H2O2 at a concentration of 100 μM or higher. How-
ever, primary cardiomyocytes were more resistant to ROS
than H9c2 cardiomyocytes. Therefore, we mainly used
H9c2 cardiomyocytes, which have been used as an alter-
native to primary cultured cardiomyocytes [14], to clearly
demonstrate the prosurvival effect of OPG.
To confirm that the H2O2-induced cell death was oxi-
dative stress mediated, the cells were pretreated with the
well-established antioxidant N-acetyl-L-cystein (NAC)
[15]. NAC pretreatment attenuated H2O2-induced acti-
vation of caspase 3 and 8 (Additional file 2: Figure S1C)
and also significantly attenuated H2O2-induced decrease of
H9c2 viability (Additional file 2: Figure S1D). Furthermore,
NAC pretreatment decreased the number of apoptotic
propidium iodide (PI)/Annexin V double-stained cells [16]
(Additional file 2: Figure S1E). Interestingly, H2O2 con-
centration up to 200 μM did not decrease the viability of
ASCs (Additional file 3: Figure S2).
Oxidative stress increased OPG production from ASCs
Both H2O2 and TGF-β1, another soluble factor com-
monly present in damaged heart [17], significantly
increased the OPG production of ASCs without
decreasing viability (Fig. 1a). Also, H2O2 significantly
increased mRNA expression of OPG and TRAIL re-
ceptor 3 (TRAIL-R3) (Additional file 4: Figure S3),
which attenuates TRAIL-induced apoptosis [18]. In the
ischemia–reperfusion (I/R)-injured heart without ASC
transplantation, OPG expression was marginal only at
day 1 after I/R injury (Fig. 1b). However, in the ASC
transplantation group, prominent OPG expression was
observed in the vicinity of transplanted ASCs, which
gradually decreased with time (Fig. 1c).
OPG protected cardiomyocytes from ROS-induced
cell death
To examine the effect of OPG on cardiomyocyte viability
under oxidative stress, the cells were exposed to H2O2
with or without OPG (1.5 and 3 ng/ml) treatment. OPG
treatment significantly protected from H2O2 (Fig. 2a)
and suppressed activation of caspase 8 without affecting
the expression of TRAIL-R2 (Fig. 2b). Both ASC condi-
tioned media with or without 48 hours of H2O2
(100 μM) conditioning (designated as H2O2CM and
NorCM, respectively) significantly attenuated H2O2-in-
duced decrease of viability in both H9c2 (Fig. 2c) and
primary (Fig. 2d) cardiomyocytes. Between NorCM and
H2O2CM, H2O2CM was more effective to prevent
H2O2-induced cardiomyocyte death.
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Downregulation of OPG offset cell protective effect of
ASC conditioned media
To validate whether the cell protective effect of the ASC
conditioned media was OPG mediated, siRNA specific
to OPG was utilized. Delivery of OPG-specific siRNA to
ASCs significantly attenuated OPG mRNA expression
(Fig. 3a) and decreased OPG production (Fig. 3b). OPG-
specific siRNA had no negative effect on the cell viability
of ASCs (Fig. 3c). However, when siRNA specific to
TRAIL-R3 was codelivered with OPG-specific siRNA,
the viability of ASCs significantly decreased (Additional
file 5: Figure S4). Finally, H2O2CM obtained from OPG-
specific siRNA-treated ASCs showed decreased protective
effect on cardiomyocytes exposed to H2O2 (Fig. 3d).
Discussion
It has been reported that TRAIL was released from the
postischemic heart soon after the onset of reperfusion
[19]. Considering ROS production, a major cause of
myocardial cell death in I/R injury [20], is an early event
in myocardial reperfusion injury, TRAIL released at the
onset of reperfusion may by associated with increased
ROS and subsequent myocardial cell death in the I/R-in-
jured heart. Therefore, we hypothesized that ASCs trans-
planted into damaged heart (i.e., I/R-injured heart where
excessive oxidative stress causes cardiac cell death [21–23])
secrete OPG, and in turn the ASC-released OPG prevents
host cardiomyocyte death by antagonizing TRAIL signaling,
which has never been tested.
Fig. 1 Oxidative stress induced OPG secretion from ACSs. (a) Amount of OPG secreted from ASCs exposed to H2O2 (100 μM) determined using an ELISA
kit specific to human OPG. Conditioned media of ASCs exposed to H2O2 up to 48 hours were used for the analysis. TGF-β1 (5 ng/ml) was included as a
soluble factor commonly present in damaged heart. Inset: viability of ASCs treated with H2O2 (100 μM) or TGF-β1 (5 ng/ml) for 48 hours. *p < 0.05
compared to untreated control. (b) Expression of OPG in ischemia–reperfusion (I/R)-injured rat heart examined by immunofluorescence staining. I/R-injured
rat heart was collected 1, 3, and 7 days after the injury without ASC transplantation, and damaged heart was stained with antibodies specific to CD90
(red), a stem cell marker, and OPG (green). Nucleus was stained with DAPI (blue). (c) Expression of OPG in I/R-injured heart with ASC transplantation
(1 × 106 cells/head). Two-dimensional immunofluorescence images were converted to 2.5D topological view images for clear presentation of staining
intensity among groups. ASC adipose-derived stem cell, OPG osteoprotegerin, TGF-β1 transforming growth factor beta 1 (Color figure online)
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To test the hypothesis in vitro, we used 100 μM of
H2O2 to simulate oxidative stress to which both host
cardiomyocytes and transplanted ASCs are exposed in
vivo. In our study, H2O2 induced cardiomyocyte death
via oxidative stress-mediated activation of apoptosis,
confirming the validity of our experimental setting
(Additional file 2: Figure S1). When ASCs were exposed
to H2O2 or transplanted to I/R-injured heart, the pro-
duction of OPG was significantly increased (Fig. 1),
suggesting that ASCs exposed to a hostile microenviron-
ment, such as I/R-injured heart, can produce OPG for
the first few days following transplantation. Further ex-
periments showed that OPG can suppress ROS-induced
apoptosis of cardiomyocytes (Fig. 2a, b) and demon-
strated that H2O2 conditioning of ASCs enhanced the
protective effect of conditioned media possibly by
increasing OPG production from ASCs (Fig. 2c, d).
Experiments using OPG-specific siRNA indicated that
the cell protective effect of ASC conditioned media was
indeed OPG mediated (Fig. 3).
One interesting observation was that ASCs were less
sensitive to H2O2 compared to cardiomyocytes (Additional
file 3: Figure S2). This might have something to do with
the increased OPG and TRAIL-R3 expression under
oxidative stress (Additional file 4: Figure S3) because
cotransfection of siRNAs specific to OPG and TRAIL-R3
significantly decreased the viability of ASCs exposed to
H2O2 (Additional file 5: Figure S4). This also suggested
that OPG and TRAIL-R3 may compensate each other in
terms of suppressing TRAIL-mediated cell death in ASCs.
Nevertheless, without any further experimental evidence,
this can only be speculated at this point. We are currently
working to elucidate more detailed underlying mecha-
nisms of OPG-mediated cardiomyocyte protection and to
validate and confirm the findings of this study in vivo for
further studies.
Fig. 2 OPG protected cardiomyocytes from ROS-induced cell death. (a) Effect of OPG on H2O2-induced cell death of H9c2 examined using a cell
counting kit. H9c2 cells were treated with 100 μM of H2O2 for 24 hours with or without OPG (1.5 and 3 ng/ml) treatment. *p < 0.05, #p < 0.05
compared to H2O2-treated group. (b) Expression of proapoptotic receptor TRAIL-R2 and activated (cleaved) caspase 8 in H9c2 cardiomyocytes
exposed to H2O2 (100 μM) for 24 hours with or without OPG treatment (1.5 and 3 ng/ml) examined by western blot analysis. (c) Effect of ASC
conditioned media with or without H2O2 conditioning on the viability of H9c2 cardiomyocytes exposed to H2O2. Normal conditioned media
of ASC (NorCM) prepared by culturing ASCs for 48 hours and conditioned media with H2O2 conditioning (H2O2CM) prepared by culturing
ASCs in the presence of 100 μM of H2O2 for 48 hours. H9c2 cells were cultured in NorCM or H2O2CM with or without addition of 100 μM of
H2O2 for 24 hours. *p < 0.05, #p < 0.05 compared to H2O2-treated group. (d) Effect of ASC conditioned media with or without H2O2 conditioning
on the viability of primary cardiomyocytes exposed to H2O2. The same experimental procedure used for H9c2 cardiomyocytes was applied to
primary cardiomyocytes. *p < 0.05, #p < 0.05 compared to H2O2-treated group. OPG osteoprotegerin, TRAIL-R2 tumor necrosis factor-related
apoptosis-inducing ligand receptor 2
Lee et al. Stem Cell Research & Therapy  (2017) 8:195 Page 4 of 6
Conclusion
In the present study we provided evidence that OPG is
an ASC-released soluble factor that can protect cardio-
myocytes from ROS-induced apoptosis for the first time.
The results of this study warrant further studies to fully
elucidate the exact nature of stem cell-released paracrine
factors and may help us to design an effective stem cell-
based therapeutic strategy in the future.
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Additional file 1: Describes additional methods including primers used
for RT-PCR. (DOCX 34 kb)
Additional file 2: Figure S1. Showing ROS-induced cardiomyocyte death.
(A) Viability of H9c2 cardiomyocytes exposed to increasing concentration
of H2O2 for 24 hours. *p < 0.05 compared to untreated control. (B) Effect
of H2O2 on viability of primary cardiomyocytes. *p < 0.05 compared to
untreated control. (C) Expression of activated (cleaved) caspase 3 and 8
in H9c2 cardiomyocytes exposed to H2O2 (100 μM) for 24 hours with or
without antioxidant N-acetyl-L-cystein (NAC) (1.5 mM). (D) Viability of
H9c2 cardiomyocytes exposed to H2O2 (100 μM) for 24 hours with or
without antioxidant NAC (1.5 mM). *p < 0.05. (E) Flow cytometry analysis
of H9c2 cardiomyocytes exposed to H2O2 (100 μM) for 24 hours with or
without antioxidant NAC (1.5 mM). PI propidium iodide. (PDF 237 kb)
Additional file 3: Figure S2. Showing effect of H2O2 on ASC viability.
*p < 0.05 compared to control. (PDF 36 kb)
Additional file 4: Figure S3. Showing ROS-induced OPG and TRAIL-R3
expression in ASCs. *p < 0.05 compared to corresponding control of each
group. (PDF 160 kb)
Additional file 5: Figure S4. Showing that OPG and TRAIL-R3 contribute
to the survival of ASCs exposed to ROS. (A) Expression of TRAIL-R3 mRNA
24 hours after transfection of siRNA specific to TRAIL-R3. 18 s-rRNA used as
internal control. (B) Effect of OPG and/or TRAIL-R3 downregulation on the
viability of ASCs exposed ROS. Cells transfected with OPG siRNA and/or TRAIL-
R3 siRNA for 24 hours and then exposed to H2O2 (100 and 200 μM) for an
additional 24 hours. *p < 0.05 compared to untreated control. (PDF 87 kb)
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ELISA: Enzyme-linked immunosorbent assay; FBS: Fetal bovine serum; H2O2CM:
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Fig. 3 Downregulation of OPG offset protective effect of ASC conditioned media. (a) OPG-siRNA-mediated downregulation of OPG in H2O2-treated
ASCs. ASCs were transfected with 20 nM of OPG-specific siRNA for 24 hours, and then exposed to 100 μM of H2O2 for an additional 48 hours. mRNA
expression of OPG normalized by 18 s rRNA expression. *p < 0.05, #p < 0.05 compared to H2O2-treated group. (b) Effect of OPG-specific siRNA on the
OPG production from ASCs exposed to H2O2. OPG-siRNA (20 nM)-transfected ASCs were cultured in the presence of 100 μM of H2O2 for 48 hours,
and the amount of OPG in ASC culture media was determined using an OPG-specific ELISA kit. *p < 0.05 compared to untreated control, #p < 0.05
compared to H2O2-treated group. (c) Viability of OPG-siRNA-transfected ASCs exposed to 100 μM of H2O2. *p < 0.05 compared to H2O2-treated group.
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